References
- Taurog JD, Chhabra A, Colbert RA. Ankylosing Spondylitis and Axial Spondyloarthritis. N Engl J Med. 2016;374(26):2563–2574.
- Reveille JD. Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. Clin Rheumatol. 2015;34(6):1009–1018.
- Prajzlerová K, Grobelná K, Pavelka K, et al. An update on biomarkers in axial spondyloarthritis. Autoimmun Rev. 2016;15(6):501–509.
- Wendling D, Guillot X, Prati C. The IL-23/Th 17 pathway in spondyloarthritis: the royal road? Joint Bone Spine. 2015;82(1):1–4.
- Wendling D. The gut in spondyloarthritis. Joint Bone Spine. 2016;83(4):401–405.
- Lavric M, Miranda-García MA, Holzinger D, et al. Alarmins firing arthritis: Helpful diagnostic tools and promising therapeutic targets. Joint Bone Spine. 2016 Sep 19. doi:10.1016/j.jbspin.2016.06.010. pii: S1297-319X(16)30127-0.
- Walsham NE, Sherwood RA. Fecal calprotectin in inflammatory bowel disease. Clin Exp Gastroenterol. 2016;9:21–29.
- Kalla R, Kennedy NA, Ventham NT, et al. Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases. Am J Gastroenterol. 2016 Sep 6. DOI:10.1038/ajg.2016.342.
- Hammer HB, Kvien TK, Glennås A, et al. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis. Clin Exp Rheumatol. 1995;13(1):59–64.
- Klingberg E, Carlsten H, Hilme E, et al. Calprotectin in ankylosing spondylitis–frequently elevated in feces, but normal in serum. Scand J Gastroenterol. 2012;47(4):435–444.
- Matzkies FG, Targan SR, Berel D, et al. Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study. Arthritis Res Ther. 2012;14(6):R261.
- Oktayoglu P, Bozkurt M, Mete N, et al. Elevated serum levels of calprotectin (myeloid-related protein 8/14) in patients with ankylosing spondylitis and its association with disease activity and quality of life. J Investig Med. 2014;62(6):880–884.
- Turina MC, Yeremenko N, Paramarta JE, et al. Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis. Arthritis Res Ther. 2014;16(4):413.
- Turina MC, Sieper J, Yeremenko N, et al. Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis. Ann Rheum Dis. 2014;73(9):1746–1748.
- Cypers H, Varkas G, Beeckman S, et al. Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. Ann Rheum Dis. 2016;75(7):1357–1362.